Getty Images
The start of this year’s HIV Research for Prevention Conference brings with it new findings show the potential of special antibodies to prevent HIV infection
This antibody can make people 75% less likely to become infected with a third of existing strains of HIV
Bhekisisa unpacks the study and breaks down the key concepts
There’s a new player in the HIV prevention field. Newly released results from the 4th HIV Research for Prevention Conference offers fresh insight into how the immune system can prevent HIV infection and serve as a guide for a potential, long-awaited HIV vaccine.
HIV antibody trial results offer proof of concept
Outcome of AMP shows feasibility of developing potent antibody combinations to block HIV March 17, 2021 • By Sabin Russell / Fred Hutch News Service Dr. Larry Corey, former president and director of Fred Hutchinson Cancer Research Center, was protocol chair of the Antibody Mediated Prevention trials and reported first results prior to the online HIV Research for Prevention scientific conference, which opened on Jan. 27. Photo by Robert Hood / Fred Hutch News Service
Editor s note: The story below was originally published on Jan. 26, 2021, upon release of the AMP results prior to an international HIV prevention conference. Details of the paired AMP trials have now been published in the March 18, 2021 edition of the
Wednesday, 27 January 2021, 7:53 am
26 January 2021 – Important advances in HIV prevention
research were announced today at the 4th
HIV Research for Prevention Conference (HIVR4P //
Virtual), convened by IAS – the International AIDS
Society.
Highlights included findings from a pair of
trials evaluating whether infusions with a broadly
neutralizing antibody (bNAb) can prevent HIV acquisition and
positive interim results from a study of long-acting
injectable pre-exposure prophylaxis (PrEP) in women. Other
announcements included promising data from a study of
islatravir as a once-monthly PrEP pill, a study warning that
many African countries are not on track to meet key UNAIDS
prevention targets, new data on global uptake of PrEP, and a
For the first time, researchers say infusions of antibodies can prevent HIV infection Source:
Corey L, et al. Abstract 1480. Presented at: HIV Research for Prevention; Jan. 27-28 and Feb. 3-4, 2021 (virtual meeting). Disclosures: Fauci reports no relevant financial disclosures. Healio could not confirm financial disclosures for Corey or Mgodi at the time of publishing. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Subscribe ADDED TO EMAIL ALERTS
You ve successfully added to your alerts. You will receive an email when new content is published.